Home › license
 

Keywords :   


Tag: license

Lionano in license agreement with Cornell for development and production of new hollow structured metal oxide anode material for LIBs

2015-08-31 17:55:31| Green Car Congress

Tags: for development material agreement

 

Pakistan Agency Grants License for New Transmission Line

2015-08-26 20:34:00| Transmission & Distribution World

Pakistan's National Power Electric Regulatory Authority has granted a Special Purpose Transmission Licence for constructing and owning transmission facilities read more

Tags: line license agency transmission

 
 

Draft Chapter 14B.130 Marijuana Regulatory License Procedure and Requirements

2015-08-26 20:03:21| PortlandOnline

Draft Chapter 14B.130 Marijuana Regulatory License Procedure and Requirements PDF Document, 169kbCategory: Marijuana Policy Program

Tags: license requirements procedure chapter

 

Removal of Special Comprehensive License Provisions

2015-08-25 10:00:00| Expeditors Newsflash - Americas Edition

Expeditors Newsflash - Americas Edition

Tags: special license comprehensive removal

 

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

2015-08-18 14:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Merck Provides Additional Update: FDA Extends Action Date for Additional sBLA in Ipilimumab-Refractory Advanced Melanoma KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy. Merck is seeking approval for KEYTRUDA, at the currently approved dose of 2 mg/kg every three weeks, for the first-line treatment of unresectable or metastatic melanoma patients. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orInvestors:Justin Holko, 908-740-1879An Phan, 908-255-6325 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: advanced review application license

 

Sites : [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] next »